SSR181507, a dopamine D₂ receptor and 5-HT(₁A) receptor ligand: evidence for mixed anxiolytic- and antidepressant-like activities.
Boulay
Denis
D
Sanofi-Aventis Research & Development, Exploratory Unit PARIS, 1 Avenue Pierre Brossolette, 91380 Chilly-Mazarin, France. denis.boulay@sanofi-aventis.com
Depoortere
Ronan
R
Louis
Caroline
C
Lacave
Martine
M
Lucas
Marie Thérèse
MT
Griebel
Guy
G